Answers are grounded in this paper and cite their sources.
Frailty is increasingly recognized as a clinically relevant measure of biological aging, yet comparable assessment tools are lacking for scalable invertebrate models. Here, we introduce a Composite Frailty Index (CFI) for the house cricket ( Acheta domesticus ) integrating automated measures of locomotion, exploration, and freezing into a quantitative framework of functional decline. Ten behavioral parameters from automated open-field tracking were normalized to age- or treatment-matched reference populations, discretized into quintiles, and combined to generate a 0–1 frailty score. Aging cohorts (young adult: 4–6 weeks; older adult: 10–12 weeks, N = 103) and mid-life (8-10 weeks) pharmacological cohorts treated with rapamycin (14 ppm), acarbose (1000 ppm), or phenylbutyrate (1000 ppm) ( N = 122) were evaluated. CFI increased with age in both sexes ( d ’s = −1.17 to −1.14; P ’s < 0.001). Rapamycin reduced late-life frailty in both sexes ( d = −1.33 to −1.31; P ’s < 0.01), whereas acarbose and phenylbutyrate produced inconclusive effects ( d ’s = −0.54 to −0.03; P ’s > 0.05). These findings establish the cricket CFI as a scalable, high-throughput platform for quantifying functional aging and evaluating candidate geroprotective interventions beyond lifespan.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: